Rivus Banks On Muscle Sparing For Obesity Edge

More information on HU6 in obesity-related heart failure backs the company’s muscle-sparing claims, but treated patients lost less than 3% of their bodyweight.    

graphic image of fat cells
• Source: Shutterstock

More from Clinical Trials

More from R&D